MM
Maxime Moulard

Highly Cited

55
Works
1,659
Citations
17
H-Index
Search Authors
Author Statistics
External Links
OpenAlex Profile ORCID Profile

Maxime Moulard

Also known as: M Moulard, M. Moulard, Maxime Moulard, Moulard, Maxime

55

Total Works

1,659

Citations

17

H-Index

26

i10-Index

Citation & Works Trend by Year
33 years active
Top Research Topics
HIV Research and Treatment (26) HIV/AIDS drug development and treatment (15) Monoclonal and Polyclonal Antibodies Research (14) Platelet Disorders and Treatments (9) Cellular transport and secretion (6)
Recent Publications
15 shown
Year Publication Title Citations Action
2026 PB2501 Evaluation of the newly standardized quantitative flow cytometry kit for detecting platelet receptors and dysfunction Research and Practice in Thrombosis and Haemostasis 0
2026 PB2503 Stability evaluation of a new synthetic Collagen Related Peptide (CRP-A) agonist compared to the equine fibrillar collagen type I-III Research and Practice in Thrombosis and Haemostasis 0
2025 Selection and optimization strategy for Rap1-targeting single-domain antibodies as platelet activation markers Research and Practice in Thrombosis and Haemostasis 0
2025 Recommendations for Accurate Target Expression Evaluation by Quantitative Flow Cytometry Cytometry Part A 3
2024 Antiproliferative Effects of Naja anchietae and Naja senegalensis Venom Peptides on Glioblastoma Cell Lines Toxins 7
2023 Stability Assessment of Fresh or Cryopreserved Whole Blood and Bone Marrow Samples from AML and B-ALL Patients to Monitor CD123 Receptor and Immune Cells Subsets Blood 0
2022 Abstract 2909: CD123-CODV-TCE bispecific T-cell engager for acute myeloid leukemia (AML): Activity on primary AML and safety in non-human primates Cancer Research 1
2015 Role of receptor occupancy assays by flow cytometry in drug development Cytometry Part B Clinical Cytometry 38
2015 Recommendations for the development and validation of flow cytometry‐based receptor occupancy assays Cytometry Part B Clinical Cytometry 31
2015 How validated receptor occupancy flow cytometry assays can impact decisions and support drug development Cytometry Part B Clinical Cytometry 14
2014 Abstract 2908: A first-in-human phase I study of SAR650984, a humanized anti-CD38 antibody in patients with CD38+ hematological malignancies: Preliminary PK and PD results of escalation phase Cancer Research 5
2014 Reciprocal regulation of human platelet function by endogenous prostanoids and through multiple prostanoid receptors European Journal of Pharmacology 28
2012 A quantitative flow cytometric assay for determining binding characteristics of chimeric, humanized and human antibodies in whole blood: Proof of principle with rituximab and ofatumumab Journal of Immunological Methods 11
2011 Comparison of a new ELISA assay with the flow cytometric assay for platelet vasodilator-associated stimulated phosphoprotein (VASP) phosphorylation in whole blood to assess P2Y12 inhibition Thrombosis and Haemostasis 21
2011 Comparison of Cell Lysis Mediated by LFB-R603 with That Mediated by Ofatumumab Against Cells Expressing Low Levels of CD20, Blood 4

Data source: OpenAlex API